U.S. FDA advisory meetings through Nov. 16 – Reuters UK

On Sept. 23, the committee will discuss pediatric-focused safety reviews for Famvir (famciclovir), Levaquin (levofloxacin), Navstel (balanced salt ophthalmic solution with hypromellose, dextrose, and glutathione), Retrovir (zidovudine), Topamax …